BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 30916775)

  • 21. Direct and Indirect Costs of Inflammatory Bowel Disease: Ten Years of Follow-up in a Danish Population-based Inception Cohort.
    Lo B; Vind I; Vester-Andersen MK; Bendtsen F; Burisch J
    J Crohns Colitis; 2020 Jan; 14(1):53-63. PubMed ID: 31076743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health Care Cost Analysis in a Population-based Inception Cohort of Inflammatory Bowel Disease Patients in the First Year of Diagnosis.
    Niewiadomski O; Studd C; Hair C; Wilson J; McNeill J; Knight R; Prewett E; Dabkowski P; Dowling D; Alexander S; Allen B; Tacey M; Connell W; Desmond P; Bell S
    J Crohns Colitis; 2015 Nov; 9(11):988-96. PubMed ID: 26129692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal Trends in the Direct Costs and Health Care Utilization Ascribable to Inflammatory Bowel Disease in the Biologic Era: Results From a Canadian Population-Based Analysis.
    Targownik LE; Kaplan GG; Witt J; Bernstein CN; Singh H; Tennakoon A; Aviña Zubieta A; Coward SB; Jones J; Kuenzig ME; Murthy SK; Nguyen GC; Peña-Sánchez JN; Benchimol EI
    Am J Gastroenterol; 2020 Jan; 115(1):128-137. PubMed ID: 31895723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of Healthcare Utilization Among Veterans with Inflammatory Bowel Disease.
    Tan MC; El-Serag HB; Hou JK
    Dig Dis Sci; 2017 Mar; 62(3):607-614. PubMed ID: 28012103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in Direct Healthcare Costs before and after the Diagnosis of Inflammatory Bowel Disease: A Nationwide Population-Based Study.
    Lee J; Im JP; Han K; Kim J; Lee HJ; Chun J; Kim JS
    Gut Liver; 2020 Jan; 14(1):89-99. PubMed ID: 31158951
    [No Abstract]   [Full Text] [Related]  

  • 26. The Effect of Initiation of Anti-TNF Therapy on the Subsequent Direct Health Care Costs of Inflammatory Bowel Disease.
    Targownik LE; Benchimol EI; Witt J; Bernstein CN; Singh H; Lix L; Tennakoon A; Zubieta AA; Coward S; Jones J; Kuenzig E; Murthy SK; Nguyen GC; Peña-Sánchez JN; Kaplan G
    Inflamm Bowel Dis; 2019 Sep; 25(10):1718-1728. PubMed ID: 31211836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Costs of inflammatory bowel disease in Germany.
    Stark R; König HH; Leidl R
    Pharmacoeconomics; 2006; 24(8):797-814. PubMed ID: 16898849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shifting Cost-drivers of Health Care Expenditures in Inflammatory Bowel Disease.
    Click B; Lopez R; Arrigain S; Schold J; Regueiro M; Rizk M
    Inflamm Bowel Dis; 2020 Jul; 26(8):1268-1275. PubMed ID: 31671186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost Burden of Crohn's Disease and Ulcerative Colitis in the 10-Year Period Before Diagnosis-A Danish Register-Based Study From 2003-2015.
    Vadstrup K; Alulis S; Borsi A; Gustafsson N; Nielsen A; Wennerström ECM; Jørgensen TR; Qvist N; Munkholm P
    Inflamm Bowel Dis; 2020 Aug; 26(9):1377-1382. PubMed ID: 31693731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health care costs associated with Australian tertiary inflammatory bowel disease care.
    Jackson B; Con D; Ma R; Gorelik A; Liew D; De Cruz P
    Scand J Gastroenterol; 2017 Aug; 52(8):851-856. PubMed ID: 28509590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term evolution of direct healthcare costs for inflammatory bowel diseases: a population-based study (2006-2015).
    Kim JW; Lee CK; Lee JK; Jeong SJ; Oh SJ; Moon JR; Kim HS; Kim HJ
    Scand J Gastroenterol; 2019 Apr; 54(4):419-426. PubMed ID: 30905222
    [No Abstract]   [Full Text] [Related]  

  • 32. Smoking is Associated with Higher Disease-related Costs and Lower Health-related Quality of Life in Inflammatory Bowel Disease.
    Severs M; Mangen MJ; van der Valk ME; Fidder HH; Dijkstra G; van der Have M; van Bodegraven AA; de Jong DJ; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; van de Meeberg PC; Mahmmod N; Ponsioen CY; Vermeijden JR; van der Meulen-de Jong AE; Pierik M; Siersema PD; Oldenburg B;
    J Crohns Colitis; 2017 Mar; 11(3):342-352. PubMed ID: 27647859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health care costs and their predictors of inflammatory bowel diseases in Germany.
    Prenzler A; Bokemeyer B; von der Schulenburg JM; Mittendorf T
    Eur J Health Econ; 2011 Jun; 12(3):273-83. PubMed ID: 20967482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Savings in social expenditures for work incapacity in patients with inflammatory bowel disease depend on access to innovative therapies in Poland.
    Zagórowicz E; Binowski G; Strządała D; Pruszko C; Kucha P; Reguła J
    Eur J Gastroenterol Hepatol; 2024 Jun; 36(6):695-703. PubMed ID: 38526938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Burden of Crohn's disease in the United States: long-term healthcare and work-loss related costs.
    Manceur AM; Ding Z; Muser E; Obando C; Voelker J; Pilon D; Kinkead F; Lafeuille MH; Lefebvre P
    J Med Econ; 2020 Oct; 23(10):1092-1101. PubMed ID: 32609019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How expensive is inflammatory bowel disease? A critical analysis.
    Odes S
    World J Gastroenterol; 2008 Nov; 14(43):6641-7. PubMed ID: 19034966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cost of early management of chronic inflammatory intestinal disease].
    Rolland N; Grandbastien B; Merle V; Gower-Rousseau C; Yzet T; Marti R; Lerebours E; Dupas JL; Czernichow P; Salomez JL; Lebrun T; Cortot A
    Gastroenterol Clin Biol; 1999 Apr; 23(4):483-8. PubMed ID: 10416112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014.
    Bähler C; Vavricka SR; Schoepfer AM; Brüngger B; Reich O
    BMC Gastroenterol; 2017 Dec; 17(1):138. PubMed ID: 29197335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Out-of-pocket Cost Burden in Pediatric Inflammatory Bowel Disease: A Cross-sectional Cohort Analysis.
    Sin AT; Damman JL; Ziring DA; Gleghorn EE; Garcia-Careaga MG; Gugig RR; Hunter AK; Burgis JC; Bass DM; Park KT
    Inflamm Bowel Dis; 2015 Jun; 21(6):1368-77. PubMed ID: 25839776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
    Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
    BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.